04/30/2025
3:17 PM | Supernus Pharmaceuticals (Filer)
| Form DEF 14A | |
04/23/2025
4:20 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2025
7:27 AM | BlackRock, Inc. (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/03/2025
3:27 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
3:17 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:34 PM | Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:40 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
4:56 PM | Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
3:13 PM | Supernus Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/24/2025
7:16 PM | DEC TIMOTHY C (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
7:18 PM | Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for SUPN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Supernus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
02/24/2025
7:20 PM | Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
7:22 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
4:47 PM | NEWHALL CHARLES W III (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
4:50 PM | Hudson Frederick M. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
4:41 PM | Sensenig Bethany (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
4:43 PM | Barlow Carrolee (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
4:45 PM | GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:48 PM | Sensenig Bethany (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:42 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:43 PM | DEC TIMOTHY C (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:44 PM | Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:45 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:47 PM | Barlow Carrolee (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:54 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
4:20 PM | ARMISTICE CAPITAL, LLC (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
4:13 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2025
3:57 PM | Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
3:33 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4/A | |
02/05/2025
3:37 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:23 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2025
3:59 PM | Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
4:01 PM | Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
4:04 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:26 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2025
3:33 PM | Hudson Frederick M. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:13 PM | Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:08 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:42 AM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:31 AM | Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
3:31 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Elon’s Terrifying Warning Forces Trump To Take Action (Ad) Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of collapse and built two of the most valuable companies in history.
Now, he's sounding the alarm about America's $36 trillion debt time bomb that could destroy the fabric of our society.As head of the Department of Government Efficiency (DOGE) under President Trump, Musk is exposing just how bad things are... Get your free gold guide! |
11/08/2024
4:00 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
3:19 PM | GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
3:08 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:11 PM | GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
3:59 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024
3:42 PM | GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/04/2024
3:19 PM | Supernus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2024
3:35 PM | MACQUARIE GROUP LTD (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/31/2024
10:55 AM | DIMENSIONAL FUND ADVISORS LP (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SC 13G | |
10/21/2024
3:48 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
3:16 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
4:03 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
3:30 PM | GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
4:00 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:03 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
3:16 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
3:18 PM | Supernus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
3:19 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2024
3:41 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2024
3:48 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/23/2024
3:20 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/22/2024
3:24 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/19/2024
3:28 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
3:14 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
3:18 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
3:53 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
4:15 PM | Supernus Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/09/2024
3:09 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy SUPN Stock Free SUPN Stock Alerts